Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cellsYannan Jia(Shanghai Jiao Tong University), Marina Konopleva(Albert Einstein College of Medicine)HaematologicaApril 20, 202310.3324/haematol.2022.281915Cited by 62SaveCiteExport RISWatch citationsRelated PapersPhase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia|Haematologica|2015|121